Top

Published in:

01-06-2017 | Images that Teach

Pitfalls of ¹⁸F-FDG PET for evaluating myocardial viability

Authors: Osamu Manabe, MD, PhD, Noriko Oyama-Manabe, MD, PhD, Masanao Naya, MD, PhD, Tadao Aikawa, MD, Mamoru Sakakibara, MD, PhD, Hiroyuki Tsutsui, MD, PhD, Nagara Tamaki, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 3/2017

Excerpt

The assessment of myocardial viability is essential for the care and treatment of myocardial infarction patients. ¹⁸F-fluorodeoxyglucose (¹⁸F-FDG) is an analog of glucose that is taken up in viable myocardial cells by the glucose transporters.1 ¹⁸F-FDG positron emission tomography (PET) is a powerful functional imaging tool for quantifying the viability of the myocardial tissue. ¹⁸F-FDG PET is also well known as an investigation of active inflammation. We showed a representative case with ¹⁸F-FDG uptake in the area with severe hypo-perfusion, which was a false-positive result of the recent myocardial infarction due to the inflammation. …

Bulluck H, White SK, Fröhlich GM, Casson SG, O’Meara C, Newton A, et al. Quantifying the area at risk in reperfused ST-segment-elevation myocardial infarction patients using hybrid cardiac positron emission tomography-magnetic resonance imaging. Circ Cardiovasc Imaging 2016;9:e003900.CrossRefPubMedPubMedCentral

Wu YW, Tadamura E, Kanao S, Yamamuro M, Marui A, Komeda M, et al. Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography. Int J Cardiovasc Imaging 2007;23:757–65.CrossRefPubMed

Manabe O, Ohira H, Yoshinaga K, Sato T, Klaipetch A, Oyama-Manabe N, et al. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis. Eur J Nucl Med Mol Imaging 2013;40:1558–66.CrossRefPubMed

Lee WW, Marinelli B, van der Laan AM, Sena BF, Gorbatov R, Leuschner F, et al. PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol 2012;59:153–63.CrossRefPubMedPubMedCentral

Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 2010;121:2437–45.CrossRefPubMedPubMedCentral

Arai AE. The cardiac magnetic resonance (CMR) approach to assessing myocardial viability. J Nucl Cardiol 2011;18:1095–102.CrossRefPubMedPubMedCentral

Reimer KA, Jennings RB. Circulation. The changing anatomic reference base of evolving myocardial infarction. Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema. Hemorrhage Acute Inflamm 1979;60:866–76.

Korkusuz H, Esters P, Huebner F, Bug R, Ackermann H, Vogl TJ. Accuracy of cardiovascular magnetic resonance in myocarditis: comparison of MR and histological findings in an animal model. J Cardiovasc Magn Reson 2010;26:49.CrossRef

Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004;109:2411–6.CrossRefPubMed

Title: Pitfalls of 18F-FDG PET for evaluating myocardial viability
Authors: Osamu Manabe, MD, PhD
Noriko Oyama-Manabe, MD, PhD
Masanao Naya, MD, PhD
Tadao Aikawa, MD
Mamoru Sakakibara, MD, PhD
Hiroyuki Tsutsui, MD, PhD
Nagara Tamaki, MD, PhD
Publication date: 01-06-2017
Publisher: Springer US
Published in: Journal of Nuclear Cardiology / Issue 3/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-016-0572-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pitfalls of ¹⁸F-FDG PET for evaluating myocardial viability

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2017

A world view of nuclear cardiology practices: Think globally, act locally

Optimizing radiation dose and imaging time with conventional myocardial perfusion SPECT: Technical aspects

Intravenous caffeine: An alternative to aminophylline to reverse adverse effects during regadenoson myocardial perfusion imaging

Cardiac sympathetic nervous system imaging with 123I-meta-iodobenzylguanidine: Perspectives from Japan and Europe

PET/MR: Yet another Tesla?

Comprehensive review on cardio-oncology: Role of multimodality imaging